Average Co-Inventor Count = 7.14
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (16 from 2,076 patents)
2. K.u. Leuven Research & Development (5 from 84 patents)
3. Aligos Therapeutics, Inc. (4 from 34 patents)
4. Janssen Pharmaceuticals, Inc. (2 from 159 patents)
5. Cellzome Limited (2 from 21 patents)
27 patents:
1. 12428427 - Methods and compositions for targeting PD-L1
2. 12404260 - Pyridine rings containing derivatives as MALT1 inhibitors
3. 12145961 - Spirobicyclic analogues
4. 12077521 - Pyrazole derivatives as MALT1 inhibitors
5. 12018015 - Methods and compositions for targeting PD-L1
6. 11993614 - Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors
7. 11883367 - 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
8. 11760761 - Methods and compositions for targeting PD-L1
9. 11760764 - Methods and compositions for targeting PD-L1
10. 11702441 - Spirobicyclic analogues
11. 11571437 - Methods of treating cancer using PRMT5 inhibitors
12. 11318157 - 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
13. 11098062 - Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors
14. 11059850 - Spirobicyclic analogues
15. 11040031 - Pyrazole derivatives as MALT1 inhibitors